Phase II study of TS-1, CPT-11 and Bevacizumab combination chemotherapy in patients with metastatic colon cancer.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 08 Jul 2016
At a glance
- Drugs Bevacizumab (Primary) ; Gimeracil/oteracil/tegafur (Primary) ; Irinotecan (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 30 Jun 2016 Status changed from recruiting to active, no longer recruiting.
- 18 Jan 2012 New trial record